Clinical Trials Browser

Phase 2 × Iodine-124 × 90 days × Clear all

NCT03841617 2026-02-17

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Phase 2 Recruiting

Neoplasm Metastasis, Thyroid Neoplasms

NCT06961084 2026-01-07

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

Phase 2 Recruiting

Thyroid Neoplasms